Ian Miller is passionate about cell and gene therapies, with extensive experience in CAR-T clinical development over the past five years. They currently oversee the clinical operations strategy and delivery of next-generation CAR-T clinical trials in NHL and leukemia after successfully managing the trial program for KYMRIAH(R). Previously, Ian held leadership roles at AstraZeneca and Novartis, focusing on data management and operational responsibilities across global teams. Ian earned an MBA from the Open University Business School and holds a BSc in Zoology from the University of Liverpool.
This person is not in any teams
This person is not in any offices